13 December 2022
Shield Therapeutics plc announces that it will provide a live investor presentation on Wednesday 14 December 2022 at 4.30pm (GMT).
Chief Executive Officer, Greg Madison, Chief Financial Officer, Hans-Peter Rudolf and Chief Medical Officer, José Menoyo, will provide an update to investors following the recent collaborative sales agreement and equity raise. Investors can sign up to Investor Meet Company for free and request to meet Shield Therapeutics plc via the following link: https://www.investormeetcompany.com/shield-therapeutics-plc/register-investor
Questions can be submitted pre-event via your IMC dashboard or in real time during the presentation, via the "Ask a Question" function. Whilst the Company may not be in a position to answer every question it receives, it will address the most prominent within the confines of regulations and information already disclosed to the market through regulatory notifications. A recording of the presentation, a PDF of the slides used, and responses to the Q&A session will be available on the Investor Meet Company platform afterwards. No new price sensitive information will be disclosed, and a PDF of the presentation will be uploaded to the Company’s website.
For further details click here